
News|Videos|February 10, 2021
The Next Steps for Amyloid Light Chain Amyloidosis Treatment
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic the next steps for his CAEL-101 findings, a treatment for patients living with amyloid light chain amyloidosis.
Advertisement
Pharmacy Times® interviewed Jason Valent, MD, of the Cleveland Clinic the next steps for his CAEL-101 findings, a treatment for patients living with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62nd American Society of Hematology Annual Meeting & Exposition.
The full conversation can be found in the video above.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
RSV Hospitalization Associated With Persistent Symptoms and Reduced Quality of Life in Adults
2
December 2025 Product Updates
3
FLEX Study Data Highlight Role of Genomic Testing in Guiding Early-Stage Breast Cancer Treatment
4
Study Links Specific Air Pollution Components to Increased Depression Risk in Older Adults
5




